Patents by Inventor Xavier SERRA HARTMANN

Xavier SERRA HARTMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine compositions for use against digital dermatitis in a mammal
    Patent number: 11331381
    Abstract: The present invention provides new pharmaceutical and vaccine compositions comprising Treponema spp. bacterins, supplemented with antigens from Treponema spp. or other digital dermatitis causative pathological agents such as but not limited to D. nodosus or F. necrophorum, for effectively immunizing susceptible mammals, preferably ungulates, against DD, in particular against bovine digital dermatitis. The present invention also identifies Treponema pedis and Treponema phagedenis as two of the etiologic agents of digital dermatitis (DD) in mammals, in particular ungulate digital dermatitis. The invention therefore also provides isolated cultures of Treponema pedis and Treponema phagedenis for effectively immunizing susceptible mammals, preferably ungulates, against DD, in particular against bovine digital dermatitis. In addition, the present invention provides methods of diagnosing DD by detecting infection with a series of specific Treponema antigens.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: May 17, 2022
    Assignee: HIPRA SCIENTIFIC, S.L.U.
    Inventors: Antoni Foix Breto, Xavier Serra Hartmann, Marta Sitjà I Arnau, Jaume Piñol Ribas, Enrique Querol Murillo
  • VACCINE COMPOSITIONS FOR USE AGAINST DIGITAL DERMATITIS IN A MAMMAL
    Publication number: 20200360498
    Abstract: The present invention provides new pharmaceutical and vaccine compositions comprising Treponema spp. bacterins, supplemented with antigens from Treponema spp. or other digital dermatitis causative pathological agents such as but not limited to D. nodosus or F. necrophorum, for effectively immunizing susceptible mammals, preferably ungulates, against DD, in particular against bovine digital dermatitis. The present invention also identifies Treponema pedis and Treponema phagedenis as two of the etiologic agents of digital dermatitis (DD) in mammals, in particular ungulate digital dermatitis. The invention therefore also provides isolated cultures of Treponema pedis and Treponema phagedenis for effectively immunizing susceptible mammals, preferably ungulates, against DD, in particular against bovine digital dermatitis. In addition, the present invention provides methods of diagnosing DD by detecting infection with a series of specific Treponema antigens.
    Type: Application
    Filed: November 16, 2018
    Publication date: November 19, 2020
    Inventors: Antoni FOIX BRETO, Xavier SERRA HARTMANN, Marta SIT JÁ ARNAU, Jaume PINOL RIBAS, Enrique QUEROL MURILLO